4 studies found for:    19414633 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Plavix, Prasugrel and Drug Eluting Stents Pilot Trial
Conditions: Coronary Artery Disease;   Platelet Aggregation Inhibitors;   PCI- Percutaneous Coronary Intervention
Interventions: Drug: Loading Dose Arm;   Drug: Maintenance Dose Arm
2 Completed Pharmacogenetic Approach to Anti-platelet Therapy for the Treatment of ST-segment Elevation Myocardial Infarction (STEMI)
Condition: STEMI
Interventions: Genetic: Point-of-Care Genetic Testing;   Drug: Prasugrel
3 Completed ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation
Conditions: Stable Coronary Artery Disease;   Acute Coronary Syndrome;   Percutaneous Coronary Intervention
Intervention: Genetic: Point-of-care genetic screening with subsequent prasugrel administration to CYP2C19*2 carriers
4 Completed Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism
Condition: Myocardial Infarction
Interventions: Drug: cilostazol;   Drug: clopidogrel (Plavix);   Genetic: CYP2C19;   Drug: aspirin (Acetylsalicylic acid)

Indicates status has not been verified in more than two years